Literature DB >> 3886694

Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis.

M Cogne, P Brasseur, J J Ballet.   

Abstract

Antibodies against Trichomonas vaginalis were detected in serum samples from 98 patients by three immunological assays. A good correlation was observed between the enzyme-linked immunosorbent assay and the immunofluorescence method, whereas it was found that the enzyme-linked immunosorbent assay correlated better with the current or past detection of organisms than did other serological methods (immunofluorescence and hemagglutination). Similar results were obtained with whole trichomonads and two T. vaginalis soluble antigenic preparations, which suggests that immunodominant moieties shared by several T. vaginalis strains were detected. The level of antibodies of the immunoglobulin A class was higher in patients with past records of trichomoniasis, but less significantly so than the total antitrichomonal antibody level. Antibodies of the four immunoglobulin G subclasses were detected. Immunoglobulin G1 antibody values were higher in female than male patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886694      PMCID: PMC271726          DOI: 10.1128/jcm.21.4.588-592.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  The establishment of various trichomonads of animals and man in axenic cultures.

Authors:  L S DIAMOND
Journal:  J Parasitol       Date:  1957-08       Impact factor: 1.276

2.  Trichomonal Vaginitis Resistant to Metranidazole.

Authors:  S C Robinson
Journal:  Can Med Assoc J       Date:  1962-04-07       Impact factor: 8.262

3.  Trichomonas vaginalis: resistance to metronidazole.

Authors:  A W Diddle
Journal:  Am J Obstet Gynecol       Date:  1967-06-15       Impact factor: 8.661

4.  Evaluation of the indirect hemagglutination technique for study of Trichomonas vaginalis infections, particularly in men.

Authors:  T Kuberski
Journal:  Sex Transm Dis       Date:  1978 Jul-Sep       Impact factor: 2.830

5.  Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions.

Authors:  D A Street; D Taylor-Robinson; J P Ackers; N F Hanna; A McMillan
Journal:  Br J Vener Dis       Date:  1982-10

6.  Host plasma proteins on the surface of pathogenic Trichomonas vaginalis.

Authors:  K M Peterson; J F Alderete
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

7.  Specific and common antigens of Trichomonas vaginalis detected by monoclonal antibodies.

Authors:  B E Torian; R J Connelly; R S Stephens; H H Stibbs
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

8.  Trichomonas vaginalis: alternative pathway activation of complement.

Authors:  T W Holbrook; R J Boackle; J Vesely; B W Parker
Journal:  Trans R Soc Trop Med Hyg       Date:  1982       Impact factor: 2.184

9.  Antigen analysis of several pathogenic strains of Trichomonas vaginalis.

Authors:  J F Alderete
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

10.  [Value of indirect immunofluorescence and passive hemagglutination reactions in the detection of urogenital trichomoniasis].

Authors:  P Brasseur; A Menard; Y Michel
Journal:  Ann Biol Clin (Paris)       Date:  1984       Impact factor: 0.459

View more
  8 in total

1.  New concepts in the diagnosis and pathogenesis of Trichomonas vaginalis.

Authors:  R Bhatt; M Abraham; D Petrin; G E Garber
Journal:  Can J Infect Dis       Date:  1996-09

Review 2.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

3.  Anti-Trichomonas vaginalis monoclonal antibodies inducing complement-dependent cytotoxicity.

Authors:  N Moav; E Draghi; A David; D Gold
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

4.  Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection.

Authors:  M C Abraham; M Desjardins; L G Filion; G E Garber
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

Review 5.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Persistence of Trichomonas vaginalis serostatus in men over time.

Authors:  Siobhan Sutcliffe; John F Alderete; Calvin Neace; Patrick A Joyce; Charlotte A Gaydos; James I A Huth; Lorelei A Mucci; Lisa B Signorello
Journal:  Cancer Causes Control       Date:  2015-07-30       Impact factor: 2.506

7.  Recombinant α-actinin subunit antigens of Trichomonas vaginalis as potential vaccine candidates in protecting against trichomoniasis.

Authors:  Yi-Ting Xie; Jiang-Mei Gao; Ya-Ping Wu; Petrus Tang; Geoff Hide; De-Hua Lai; Zhao-Rong Lun
Journal:  Parasit Vectors       Date:  2017-02-16       Impact factor: 3.876

8.  Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia.

Authors:  Jamshaid Iqbal; Jumanah Al-Rashed; Elijah O Kehinde
Journal:  BMC Infect Dis       Date:  2016-09-23       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.